Translation, Cross-cultural Adaptation and Validation of the MGQOL-15-F
NCT ID: NCT02470364
Last Updated: 2015-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of a French-language Version of Quality of Life Questionnaires in Patients With Peripheral Facial Palsy
NCT03581253
Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1
NCT01851135
Evaluation of the Prevalence of Oculomotor Disorders in Patients With Radiologically Isolated Syndrome
NCT03636789
Multimodal Quantified Analysis of Facial Movements: Comparison Between Pathological and Control Subjects
NCT05581680
Dysfunctions and Plasticity Mechanisms of Motor System Assessed by Cortico-cortical and Cortico-muscular Coherence Analysis in Amyotrophic Lateral Sclerosis
NCT01959373
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Step 1: Translation and cultural adaptation (Forward and back translation, committee review, pre-testing with 10 patients for content and face validity).
Step 2 : Psychometric testing : Test-retest with a 2 day interval, correlation with clinical scores - the Myasthenic Muscle Score and the (MG-ADL) score and with a global quality of life score (WHOQOL-BREF).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years old
* Clinical Classification (MGFA) I-IV
* French speaking
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simone Birnbaum, Physiotherapist
Role: PRINCIPAL_INVESTIGATOR
Institute of Myology, La Pitié-Salpêtrière Hospital, 75013 Paris, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Myology, La Pitié-Salpêtrière Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MGQOL-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.